China’s biotech firms challenge US with rapidly developing RAS-targeted cancer therapies
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-07-08 16:00 UTC+10:00
Section: Revolution Medicines
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Property, Asia, China, Drugs, World News, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
The rapid development of China’s RAS-targeted cancer drugs could reshape global oncology and unlock the country’s undervalued biotech firms
--------------------------------------------------------------------